Quick Answer
BIOTRICITY INC. reported Cash and Equivalents of $365.1 thousand for fiscal year 2025.
BIOTRICITY INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $365.1K | -53.5% |
| 2024 | $786.1K | +37.8% |
| 2023 | $570.5K | -95.3% |
| 2022 | $12.07M | +448.1% |
| 2021 | $2.20M | +131.8% |
| 2020 | $949.8K | +1392.4% |
| 2019 | $63.6K | -92.5% |
| 2018 | $843.6K | +98.6% |
| 2017 | $424.9K | +1956.6% |
| 2016 | $20.7K | -61.5% |
| 2016 | $53.6K | -86.9% |
| 2015 | $410.6K | +9210.7% |
| 2015 | $4.4K | -99.0% |
| 2014 | $448.6K | — |
| 2014 | $0.00 | — |
| 2013 | $0.00 | — |
| 2012 | $0.00 | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $256.4K | -49.7% | -16.9% |
| September 30, 2025 | $308.5K | +78.0% | -21.2% |
| June 30, 2025 | $391.3K | +288.5% | +7.2% |
| March 31, 2025 | $365.1K | -53.5% | -28.3% |
| December 31, 2024 | $509.6K | +498.9% | +194.1% |
| September 30, 2024 | $173.3K | -85.6% | +72.0% |
| June 30, 2024 | $100.7K | +95.8% | -87.2% |
| March 31, 2024 | $786.1K | +37.8% | +823.8% |
- BIOTRICITY INC. showed a decrease of -53.5% in Cash and Equivalents compared to the prior fiscal year.
- The most recent figure is from BIOTRICITY INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on July 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: